Skip to main content
OpenTrials
Completed

NCT Number: NCT06933290

Effect of Flavored, Carbonated Drinks on Salivary Flow, Salivary Composition, and Taste Perceptions

To determine the effect of flavored, carbonated drinks on salivary flow rate, saliva composition, and taste perceptions compared with control drinks (water, carbonated water, non-carbonated)

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gatorade Sports Science Institute

Valhalla, New York, 10595, United States

About this study

Previous studies have shown that drinking a beverage can stimulate the production of saliva and alter its composition. These effects could impact oral processing and taste perceptions. Various ingredients in beverages such as carbonation may affect saliva and oral processing. The objective of this study is to determine the effect of flavored carbonated beverages on salivary flow rate, saliva composition (pH, mucins, carbonic anhydrase, and total protein), and taste perceptions compared with unflavored and non-carbonated control drinks.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is male or female
  • If female, subject is not pregnant or nursing (based on self-report)
  • Subject is 18-45 years of age, inclusive
  • Subject is a regular consumer of carbonated drinks (questionnaire)
  • Subject is willing to avoid alcohol consumption 24 hours prior to visits
  • Subject is willing to fast (no food or gum) for 2 hours prior to study sessions
  • Able to speak, write, and read English
  • Provision of written consent to participate

Exclusion criteria

  • Subject smokes, vapes, or uses any nicotine/tobacco products (or has quit for less than 6 months)
  • Subject currently has or recently had an illness (cold, flu, COVID) within the past month
  • Subject has a condition affecting the oral cavity such as Xerostomia (dry mouth), Sores/lesions, Untreated dental caries, Major dental implants/appliances (including dentures)
  • Subject has a reduced sense of taste (dysgeusia) or smell (parosmia)
  • Subject has a health condition that would interfere with the study as indicated on the general health questionnaire (GHQ) (including cardiovascular, renal, or metabolic diseases)
  • Subject has participated in a clinical trial within the past 30 days
  • Subject has participated in any PepsiCo trial within past 6 months
  • Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk
  • Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any PepsiCo product. If subject is unsure if a company would be considered a competitor to PepsiCo, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.

Treatment and study plan

Beverage

Other

15 milliliter aliquot interspersed with tastants with a 3 minute break between tastants

Primary outcomes

  1. Salivary flow rate

    Time frame: At each of six 2 hour test sessions 2-8 days apart at same time of day

    5 minute passive drool saliva and 10 minute filter paper saliva (one sample each from tongue and palate) collected in a fixed sequence of tastant flavors (same for each session) and the assigned test beverage intervention (different for each session)

Secondary outcomes

  1. Salivary pH

    Time frame: Sequence of repeated sampling over 2 hours on each of 6 test days with a different beverage and the same tastants each test day

    Lab test

  2. Saliva carbonic anhydrase concentration

    Time frame: Sequence of repeated sampling over 2 hours on each of 6 test days with a different beverage and the same tastants each test day

    Lab test, unit mg/L

  3. Saliva total protein concentration

    Time frame: Sequence of repeated sampling over 2 hours on each of 6 test days with a different beverage and the same tastants each test day

    Lab test, unit mg/ml

  4. Saliva mucin 5B concentration Saliva mucin 5B concentration

    Time frame: Sequence of repeated sampling over 2 hours on each of 6 test days with a different beverage and the same tastants each test day

    Lab test, unit micrograms/ml

  5. Saliva mucin 7 concentration

    Time frame: Sequence of repeated sampling over 2 hours on each of 6 test days with a different beverage and the same tastants each test day

    Lab test, unit micrograms/ml

  6. Taste perceptions

    Time frame: Sequence of repeated sampling over 2 hours on each of 6 test days with a different beverage and the same tastants each test day.

    Labeled Magnitude Scale (LMS)) of intensity of perception rated from barely detectable to strongest imaginable (tastants such as sweet, sour, salty, bitter, umami).

  7. Beverage liking

    Time frame: Sequence of repeated sampling over 2 hours on each of 6 test days with a different beverage and the same tastants each test day

    9-point hedonic scale rating from 1=Dislike extremely to 9= Like extremely

  8. Adverse Events

    Time frame: Symptoms reported at each test day and between visits from Screening to test day six

    Safety

Sponsors and collaborators

Lead sponsor

PepsiCo Global R&D

Industry

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 18, 2025
Registry last updated
Jun 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.